about
Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ₃ for staging liver fibrosis in rat model.Detection of high-risk atherosclerotic plaques with ultrasound molecular imaging of glycoprotein IIb/IIIa receptor on activated platelets.Preparation of RGD-modified long circulating liposome loading matrine, and its in vitro anti-cancer effects.Cyclic arginine-glycine-aspartate attenuates acute lung injury in mice after intestinal ischemia/reperfusion.In vivo near-infrared fluorescence imaging of apoptosis using histone H1-targeting peptide probe after anti-cancer treatment with cisplatin and cetuximab for early decision on tumor responseBiodistribution of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer drug delivery.Bioactive coatings for orthopaedic implants-recent trends in development of implant coatings.Alginate: properties and biomedical applications.Modulation of intercellular junctions by cyclic-ADT peptides as a method to reversibly increase blood-brain barrier permeability.Methotrexate (MTX)-cIBR conjugate for targeting MTX to leukocytes: conjugate stability and in vivo efficacy in suppressing rheumatoid arthritis.Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃.Motif mimetic of epsin perturbs tumor growth and metastasisCyclic-RGD peptides increase the adenoviral transduction of human mesenchymal stem cells.Comparison of Linear and Cyclic His-Ala-Val Peptides in Modulating the Blood-Brain Barrier Permeability: Impact on Delivery of Molecules to the Brain.Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.Cyclic arginine-glycine-aspartate peptides enhance three-dimensional stem cell osteogenic differentiation.Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles.The role of thiols and disulfides on protein stability.Peptide-based imaging agents for cancer detection.Targetable HPMA copolymer-aminohexylgeldanamycin conjugates for prostate cancer therapy.Peptide targeted lipid nanoparticles for anticancer drug delivery.A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy.Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment.Surface functionalization of polymeric nanoparticles for tumor drug delivery: approaches and challenges.Nylon-3 polymers that enable selective culture of endothelial cellsA specific cell-penetrating peptide induces apoptosis in SKOV3 cells by down-regulation of Bcl-2.Noninvasively characterizing the different alphavbeta3 expression patterns in lung cancers with RGD-USPIO using a clinical 3.0T MR scannerA Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins.A novel vascular homing peptide strategy to selectively enhance pulmonary drug efficacy in pulmonary arterial hypertension.The role of covalent dimerization on the physical and chemical stability of the EC1 domain of human E-cadherin.An optimized intein-mediated protein ligation approach for the efficient cyclization of cysteine-rich proteins.N-terminus 4-Chloromethyl Thiazole Peptide as a Macrocyclization Tool in the Synthesis of Cyclic Peptides: Application to the Synthesis of Conformationally Constrained RGD-Containing Integrin Ligands.Strongly binding cell-adhesive polypeptides of programmable valencies.Scaffold materials from glycosylated and PEGylated bovine serum albumin.Metal ion interactions with mAbs: Part 1.Osteoblastic potency of bone marrow cells cultivated on functionalized biometals with cyclic RGD-peptide.Integrin-targeted nano-sized polymeric systems for paclitaxel conjugation: a comparative study.The Use of Biocompatible Alginate Scaffolds Covalently Modified with Cyclic RGDfK Peptides to Improve Survival of Transplanted Cells and Angiogenesis in Damaged Myocardium.Highly sensitive SERS analysis of the cyclic Arg-Gly-Asp peptide ligands of cells using nanogap antennas.Crosslinked Platform Coatings Incorporating Bioactive Signals for the Control of Biointerfacial Interactions.
P2860
Q30386588-8A79695C-D915-496B-869D-E34F929F2FF7Q30408017-83A2395E-3A35-48FB-ADEA-B9D8F4AC4FBDQ33623605-60C6FA77-F06E-42F8-84A4-AE5B611E567AQ33754734-0B153143-5CC2-4A86-A68F-72FEDD04A06BQ33784343-CFBB6C47-DDA1-4B9E-9B7D-9EA2F10D99D4Q33836864-3AC99251-E8EA-44D1-B088-758142A7F529Q34072309-49CDACC5-7641-4585-A0C3-E35668F2E5DFQ34236679-5475C23B-4BF9-4940-AA5C-DA08970D7708Q35642174-1CB08027-83DA-446C-8F9A-BE2DE7939B32Q35759924-174F3FA1-58A3-4BBA-B041-4BF8FE0F66A1Q36113183-CCFE1678-BC52-47B9-9BA8-D93CE2BDC424Q36335923-62639C73-C33C-48F0-B905-009D4A578B0DQ36587726-9FAD73BA-A356-4E36-8036-1DDD0061F2F7Q36587860-512BA9A6-0937-4E3D-A32B-6B5017CBC894Q36690711-9C5C9ECE-8244-417D-AA4F-3168348C0729Q37414061-569679CD-D6CF-4AC2-AD3F-F24AF2C73C32Q37426880-9D55FF48-7A19-4EA7-A0BC-32ACF5D7AD4BQ37524089-AFF40C1D-45CF-4694-A335-72A44E97F4B8Q37585965-41B4E4B2-C184-4B69-9C7A-B7E3F5F37E5BQ37635384-7351EE08-79B1-44C0-B91B-BCED3C8C8959Q38016810-60EB11F3-0EE0-4613-81AF-D7F905A7D0A1Q38047231-B714BB61-F9AD-4475-A8AA-3751DBF7ADF0Q38787442-1FE2BE41-E8E8-4063-984A-4C23D084738BQ38899902-28870776-E68B-4AE1-AE18-4C26C2423CE0Q38911376-6FCB26A1-3272-43CC-98BA-D44A55C29869Q39135521-E3ADF467-F345-430E-A289-4D0A97FEB6F4Q39763187-D6F11E7A-1E69-434C-BF92-2317BBD85200Q41195862-2CFE0D32-95D3-4664-B33B-0F180F1D678CQ41882126-71C9D083-5940-4F1E-A268-363C65F1CE11Q42051766-1DC5E280-17DD-44E8-9215-5563AC0827E9Q42183144-384F0A73-EE78-48A7-B5AD-EBFF941D81D5Q42689287-A194C7A8-97E7-42BF-B916-7072BD3C5AB7Q42829590-34E9FB06-DB4D-4F11-8C5E-97277126357FQ42830290-50911EBA-BB54-4D01-A455-019B79384854Q43199899-DFF9C84D-5E2C-409D-AD2D-ACF16BC39ACEQ44571602-FBF4F2A0-F124-4EB6-AA78-C0C5FF9FB7F1Q47959735-6098EF21-ED7A-43EC-8331-CFD2935EC4EFQ48653172-0596F970-1A4B-4925-9AA1-702B2AE0E8E8Q51348989-30FBDCDE-43D8-4E7B-9D25-7240DDD94414Q51373454-91549076-D24C-49D2-A34C-387E4032B7BA
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Solution stability of linear vs. cyclic RGD peptides.
@ast
Solution stability of linear vs. cyclic RGD peptides.
@en
type
label
Solution stability of linear vs. cyclic RGD peptides.
@ast
Solution stability of linear vs. cyclic RGD peptides.
@en
prefLabel
Solution stability of linear vs. cyclic RGD peptides.
@ast
Solution stability of linear vs. cyclic RGD peptides.
@en
P2093
P2860
P1476
Solution stability of linear vs. cyclic RGD peptides.
@en
P2093
Bogdanowich-Knipp SJ
Chakrabarti S
Dillman RK
Siahaan TJ
Williams TD
P2860
P304
P356
10.1034/J.1399-3011.1999.00052.X
P577
1999-05-01T00:00:00Z